These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Busatto GF; Pilowsky LS; Costa DC; Ell PJ; David AS; Lucey JV; Kerwin RW Am J Psychiatry; 1997 Jan; 154(1):56-63. PubMed ID: 8988959 [TBL] [Abstract][Full Text] [Related]
8. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers. Niesters M; Khalili-Mahani N; Martini C; Aarts L; van Gerven J; van Buchem MA; Dahan A; Rombouts S Anesthesiology; 2012 Oct; 117(4):868-77. PubMed ID: 22890117 [TBL] [Abstract][Full Text] [Related]
9. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. Northoff G; Steinke R; Czcervenka C; Krause R; Ulrich S; Danos P; Kropf D; Otto H; Bogerts B J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):445-50. PubMed ID: 10486389 [TBL] [Abstract][Full Text] [Related]
16. Probing GABA receptor function in schizophrenia with iomazenil. Ahn K; Gil R; Seibyl J; Sewell RA; D'Souza DC Neuropsychopharmacology; 2011 Feb; 36(3):677-83. PubMed ID: 21068719 [TBL] [Abstract][Full Text] [Related]
17. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. Abi-Dargham A; Laruelle M; Seibyl J; Rattner Z; Baldwin RM; Zoghbi SS; Zea-Ponce Y; Bremner JD; Hyde TM; Charney DS J Nucl Med; 1994 Feb; 35(2):228-38. PubMed ID: 8294990 [TBL] [Abstract][Full Text] [Related]
18. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study. Stone JM; Erlandsson K; Arstad E; Squassante L; Teneggi V; Bressan RA; Krystal JH; Ell PJ; Pilowsky LS Psychopharmacology (Berl); 2008 Apr; 197(3):401-8. PubMed ID: 18176855 [TBL] [Abstract][Full Text] [Related]
19. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model. Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750 [TBL] [Abstract][Full Text] [Related]
20. 123I-iomazenil as a clinical tool for studying neuronal loss. Postiglione A; Soricelli ; Salvatore M; Lassen NA J Am Geriatr Soc; 1997 Apr; 45(4):534-6. PubMed ID: 9100734 [No Abstract] [Full Text] [Related] [Next] [New Search]